…entioned In Important Disclosures Ticker Company Name WEED Canopy Growth Corporation GWPH GW Pharmaceuticals Plc TLRY Tilray TPB Turning Point Brands Important Disclosures and Information Relating to Cowen Washington Research Group Cowen Washington Research Group produces co...
Results for “Tilray”
Search across the indexed text of every released document.
Names that match “Tilray”
9 documents found
Tilray entered a partnership with Alef Biotechnology (now Tilray Latin
…an MOU with Dayacann in January 2019 to further expand into the Chilean market of around 1.8 million patients. In 2018, Tilray entered a partnership with Alef Biotechnology (now Tilray Latin America) for distribution in Chile and Brazil, and recently received a license to cultiva...
…21 public and private operators that currently have exposure to the category, including Outperform rated Canopy Growth, Tilray and Turning Point Brands, which have all announced plans to enter the U.S. CBD market. The Science of CBD (Nadeau) Cannabis’s therapeutic potential is...
$150 PT). Canadian-based Tilray (NASD: TLRY)
including Tilray’s recently announced acquisition of Manitoba
such as products from Tilray or Bedrocan
… Apr 16 Jul 16 Oct 16 Jan 17 Apr 17 Jul 17 Oct 17 Jan 18 Apr 18 Jul 18 Oct 18 Jan 19 Closing Price ———— Target Price Tilray Rating History as of 02/25/2019 powered by: BlueMatrix 1:(1):$34.00 | | (1):$62.00 | | (4):$172.00 | |(1):$150.00 08/13/18 08/29/18 | | 10/09/18 11418...
…ceuticals, is undergoing the licensing process. “Unlicensed” products may be able to be obtained, such as products from Tilray or Bedrocan, under special circumstances which are unmet by other licensed products. Canopy and Aurora announced at the beginning of 2019 that it plans t...